Navigation Links
Cascades Technologies, Inc. Chosen to Deliver IT Support on a DoD Blast Injury Research Program
Date:11/18/2008

HERNDON, Va., Nov. 18 /PRNewswire-USNewswire/ -- Cascades Technologies, Inc. (CTi), a federal government professional consulting firm, announced that it was chosen to provide a variety of web-based services in support of DoD's Blast Injury Research Program. Working closely with prime contractor Science Applications International Corporation (NYSE: SAI) and the Blast Injury Research Program Coordinating Office (PCO) at the U.S. Army Medical Research and Materiel Command (USAMRMC), CTi will support Phase 3 of the project after having successfully supported the first two phases of the program.

Established in July 2006 by DoD Directive 6025.21E (Medical Research for Prevention, Mitigation, and Treatment of Blast Injuries), the purpose of the program is to coordinate and manage relevant DoD research efforts and programs for the prevention, mitigation, and treatment of blast injuries. Leveraging research and expertise from both within and outside the DoD, the Blast Injury Research Program is focused on filling knowledge gaps in three key topic areas--Injury Prevention, Acute Treatment, and Reset (activities necessary to return injured war fighters to duty readiness or ensuring a healthy return to civilian life).

"The debt we owe our brave war fighters for their sacrifices is immeasurable, therefore, we are deeply honored to do our part to help ensure everything is done to try to minimize the loss of life, improve the quality of life and reduce the long term impact of blast-related traumas faced by our men and women in uniform," said Alfredo Casta, President and CEO of Cascades Technologies, Inc. SAIC senior vice president and business unit general manager Robert McCord added, "Nothing we do is more important than the service we provide to help ensure our military personnel can be successful and safe."

Among some of the Program's early accomplishments include advanced simulation of blast-induced brain injuries to improve the design of personal protective equipment, development of a prototype agent using freeze-dried platelets that improves clotting time and clot strength to facilitate wound-healing, procedures and products that may lengthen amputated fingers and restore function to blast-injured limbs and faces. Dozens of other accomplishments and medical breakthroughs are listed on the Program's new website.

Under Phase 3, CTi will design, develop and maintain databases for collecting, managing and analyzing blast injury research program data from summaries of ongoing clinical research to program budget data and much more. CTi will also manage the content for an informational website to disseminate blast injury research program information to the public, DoD leadership and researchers, to include research publications, upcoming events, and news items. Additionally, CTi will develop and maintain a web-based, password-protected program management system for collecting and sharing information among DoD blast injury researchers.

CTi's innovative Puerto Rico Applications Development And Support center (PRADAS) will develop the bulk of the software working closely with CTi's Headquarters Program Management Office, SAIC, and the staff at the Blast Injury Research PCO. The CTi team will apply CMMI Level 2 best practices in support of this effort.

Cascades Technologies, Inc. (CTi), is a customer-focused professional consulting firm committed to acting as a reliable advisor to its clients; driving efficiency and productivity, resulting in improved services. From diagnosis to solutions, CTi identifies areas of improvement and helps deliver results, including customized technology applications specific to the client's needs. An 8(a) certified, Hispanic-owned business, CTi's primary customers are civilian agencies within the Federal government and various health related entities. In addition to its Herndon, VA headquarters, CTi has established offices in Washington, DC, and San Juan, Puerto Rico.

To learn more about Cascades Technologies, Inc. (CTi), call 703.793.7222 or visit www.cascadestech.com


'/>"/>
SOURCE Cascades Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. GSA Selects Cascades Technologies, Inc. (CTi) to Support USA.gov
2. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
3. Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel
4. Microchip Biotechnologies, Inc. Secures Exclusive License to Use New University of Alberta Technology for Developing Microfluidic Devices
5. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
6. Neurobiological Technologies, Inc. Reports Receipt of Notice From Nasdaq
7. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007
8. Neurobiological Technologies, Inc. Reports Fourth Quarter and Fiscal Year-End Financial Results for 2007 Announces 1-for-7 Reverse Stock Split
9. Neurobiological Technologies, Inc. (Nasdaq: NTIID)
10. Emisphere Technologies, Inc. and Eli Lilly and Company Settle Ongoing Litigation
11. Maven Biotechnologies, LLC to Present at BIOCOM Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... DUBLIN , Jan 19, 2017 Research ... Market by Profiling Technology, Biomolecules, Cancer Type, Application - Global Opportunity ... ... Report, forecasts that the global market is projected to reach $15,737 ... of 13% from 2016 to 2022. Omic technologies ...
(Date:1/19/2017)... and HOUSTON , ... ("NX Prenatal") today announced the formation of its ... leading clinicians and industry veterans who enhance the ... as it accelerates development of its novel prenatal ... provide medical, clinical and strategic guidance for the ...
(Date:1/19/2017)... Jan 19, 2017 Research and Markets ... has announced the addition of the ... - Forecast to 2025" report to their offering. ... The report provides a detailed analysis on current and future market ... 2025, using estimated market values as the base numbers ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... software to leading biopharmaceutical and medical device manufacturers and regulators, is proud to ... CFR Part 11-compliant email client designed to provide product vigilance departments with the ...
Breaking Biology Technology:
(Date:1/12/2017)... DIEGO , Jan. 12, 2017  Trovagene, Inc. ... tumor DNA (ctDNA) technologies, today announced that it has ... Europe and the Middle East ... tests.  This milestone marks the first wave of international ... for urine and blood samples. The initial ...
(Date:1/11/2017)... , Jan. 11, 2017  Michael Johnson, co-founder of Visikol ... Capital Group, Inc., has been named to the elite "Forbes 30 ...  was one of 600 people in 20 fields nationwide to be ... of the 15,000 applicants were selected. ... He is currently a PhD candidate at Rutgers ...
(Date:1/4/2017)... , Jan. 4, 2017  For the thousands of attendees at ... global leader in connected health and biometric measurement devices and services, will ... On display in A&D Medical,s special CES Exhibit Suite ... the ongoing expansion of the company,s WellnessConnected product platform.  ... ...
Breaking Biology News(10 mins):